LMEDLINE
Subject
Coverage

All areas in the broad field of biomedicine.

File Type

Bibliographic

Features

Thesauri:Chemical Name (/CN), Controlled Term (/CT)
MeSH Tree Number (/MN)
The thesauri do not apply to terms in the OLDMEDLINE file segment.

CAS Registry®
Number IdentifiersPage Images



STN AnaVist™

Keep & Share




SLART




STN Easy

Learning Database

Structures

®




®

RecordContent

•
•
•
•
•
•
•

File Size

Approximately 18,686 records from OLDMEDLINE and MEDLINE (4/2017)

Coverage

Selected from 1948-present

Updates

None

Language

English

Database
Producer

U.S. National Library of Medicine (NLM)
8600 Rockville Pike
Bethesda, MD 20894 USA
Phone: 301-594-5983
Phone: 888-346-3656

SourcesOver 5,300 journal titles published in over 70 countries are currently indexed in the full
MEDLINE database

User Aids••••

Clusters

LEARNING
STN Database Clusters information (PDF)

PricingEnter HELP COST at an arrow prompt (=>).

®

LMEDLINE is a static training database intended for learning how to use MEDLINE .
Over 99% of MEDLINE's citations are references to journal articles
Approximately 50% of the citations contain abstracts
Records added before 1975 do not have abstracts
MEDLINE reference data is present in the file
CAS Registry Numbers are present in the file
About 75% of MEDLINE's citations represent publication in the English language

Medical Subject Headings - MeSH Browser: http://www.nlm.nih.gov/mesh/
List of Serials Indexed for Online Users: http://www.nlm.nih.gov/tsd/serials/lsiou.html
STNGUIDE
Online Helps (HELP DIRECTORY lists help messages available)

April 2017

2
LMEDLINE

Search and Display Field Codes
NLM represents that the databases provided hereunder were formulated with a reasonable standard of care. NLM makes norepresentations or warranties, expressed or implied, including but not limited to, any implied warranty of merchantability or
fitness for a particular purpose, with respect to such databases and specifically disclaims all such warranties andrepresentations. Some material in these databases is from copyrighted publications of the respective copyright claimants.
Users of the databases are referred to the publications data appearing in the bibliographic citations, as well as to the
copyright notices appearing in the original publication, all of which are hereby incorporated by reference.
The fields that allow left truncation are marked with an asterisk (*).
SearchCode

Search Field Name

Display
Codes

Search Examples

Basic Index * (contains single words fromthe title (TI), chemical name (CN), genename (GEN), controlled term (excluding
MeSH numbers) (CT), supplementaryterm (ST), named person (NA), othersource (OS), and abstract (AB) fields, aswell as CAS Registry Numbers and®
GenBank Numbers)

None (or /BI)S INTERFERON GAMMA
S 50-02-2
S GENBANK D64071
S HEART (S) TEST#S ?FERON?
S EC3.1.3.13
S GAMMA (S) INTERFERONAB, CN, CT,
GEN, NA, OS,
RN, ST, TI

Abstract *

/AB

AB

Abstract Languages (other) (3)Accession Number

/ABLA
/AN

Accession Number of the Cited Referencein MEDLINE
AuthorAuthor Group
Author Identifier
Chemical Name (1)/RAN.MED

S ?ASSAY?/AB
S RADIOACTIVE TRACER/AB
S (LEUKEMIA (S) GLEEVEC)/ABS SPANISH/ABLAS 1965153674/AN
S 1998010009/AN
S 1967176588/RAN.MED

AU
AUTH
AUID
CN, RN

Chemical Name Segment * (1)Cited Reference First Author Name
Cited Reference First Author Name,
Extended (12)Cited Reference Count (6)Cited Reference Issue Number
Cited Reference Page Number
Cited Reference Publication Year
Cited Reference Source Publication
Cited Reference Volume Number

/CNS
/RAU
/RAU.EXS ADAMSON G?/AU
S BROOKS A?/AUTH
S 0000-0001-8859-5034/AUID
S NIFEDIPINE/CN
S EC 1.11.1.6/CN
S ?FLUOR?/CNSS DEANDRADE A L/RAU
S WALKER J M?/RAU.EX/RE.CNT
/RIS
/RPG
/RPY
/RSO
/RVL

S 15-20/RE.CNT
S 12/RISS 32/RPG
S 2007/RPY
S JAMA/RSO
S 22/RVL

RE.CNT
RE
RE
RE
RE
RE

Cited Reference Source Publication Name
Cited References
Cited References, Extended (12)Citing Reference Accession Numbers(limit 50)
Citing Reference Count (6)S MED ARTS SCI/RWKS DELPHIA J M?/RES WALKER J M?/RE.EX
S 2014206241/OS.G

Clinical Trial Numbers

/RWK
/RE
/RE.EX/OS.G (or/OS.CITING.AN)/OSC.G(/CITING.CNT)
/NCT

RE
RE
RE
OS.G,
OS.CITING.AN
OSC.G,CITING.CNT
NCT

Collaborators
Comment
Controlled Term (2) (includes main terms)

/AUCL
/CM
/CT

Corporate Source (3,4) (includes Collective
Name)
Country of Publication (ISO code and text)

/CS

/AU
/AUTH
/AUID
/CN

/CY

S 13/OSC.GS ISRCTN03464021/NCT
S NCT00005487/NCT
S BEGAY JACK/AUCLS TOXICOL?/CM
S OVARIAN FOLLICLE/CT
S (HYPERTENSION(L)BL)/CT
S (C14.907.489. (L) TH)/CTS *BRAIN/CT
S (KYUSHU(W)CANCER(W)CENTER)/CSS ROSIGLITAZONE STUDY GROUP/CS
S L1 AND UNITED STATES/CY
S JP/CY

ABLA
AN
RE

CN, RN
RE
RE

AUCL
CM
CT

CS
CY
April 2017

3
LMEDLINE

Search and Display Field Codes (cont'd)
SearchCode

Search Field Name

Display
Codes

Search Examples

Digital Object Identifier
Document Number (contains MEDLINEDN and the PubMed ID number)/FTDOI (or /DOI)/DN

S 10.11?/FTDOIS 9875853/DN
S 6000001/DN
S 11300629/DN

DOI, FTDOIDNDocument Type (code and text) (5)/DT(or /TC)
/EPD
/EPY
/EML
/ED
/EM
/FA
/FS

S MULTICENTER STUDY/DT
S BIO/TC
S 21 DEC 2012
S 2013/EPY
S B.A.BRIDGES@SUSSEX.AC.UK/EML
S ED>20020500
S 199106/EM
S L2 AND AB/FA
S L8 AND PRIORITY JOURNALS/FS
S B/FSS DIABETES AND OLD/FSS IN-PROCESS/FSS CLINICAL TRIALS.GOV/FSS C-JUN/GEN
S R01 HG005220/GN
S NHGRI/GOS DALLAS EVE/AUGR
S 8756-8160/ISNDT

S BIOCHEM PHARMACOL/JTS BIOCHEMICAL PHARMACOLOGY/JT
S 0101032/JTC
S GERMAN/LAS RU/LAS 5-10/REM.CNTS PRIMROSE J/NA
S NASA-00001303/NR
S NASA/NR
S CLML5936/OS
S GENBANK L02896/OS
S 2005 OCT 4/PD
S L1 AND 1990-1992/PY
S 0006-2952/SO
S BIOCHEM PHARMACOL/SO
S 7802429/SO
S NASA00001303/SO
S FLIGHT EXPERIMENT/SO

JT, SOS TOOTH MOVEMENT/TIS TE7660XO1C /UNIIS UP>20030200 AND L4
S UPI>20140528
S 20140107/UPOS.G
S CITING.UP>20140107

TI
UNII
ED
ED, UPI
UPOS.G, UPOG,
CITING.UP

Electronic Publication Date (6)Electronic Publication Year (6)Email Address (3)Entry Date (6)Entry Month (6)Field Availability (7)File Segment (8)Gene Name (3,9)
Grant Number (3)Grant Organization
Group Authors
International Standard (Document)
Number (contains CODEN, if available,
and ISSN)
Journal Title (contains full andabbreviated journal titles)
Journal Title Code (3)Language (ISO code and text)

/GEN
/GN
/GO
/AUGR
/ISN

MEDLINE Cited References Count (6)Named Person (10)Number of Report (3)/REM.CNT/NA/NR

Other Sources (3,11)/OS

Publication Date (6)Publication Year (6)Source (contains full and abbreviatedjournal titles, ISSN, CODEN, journal
title code, number of report, space flight
mission, investigator, and affiliation
data, call number, publication year,
volume, issue, and pagination)
Title *
Unique Ingredient Identifier
Update Date (6)Update Date Indexing Added (6)Date Last Citing Reference Entered STN
(6)

/PD
/PY
/SO

(1)

(2)

/JT
/JTC
/LA

/TI
/UNII
/UP
/UPI
/UPOS.G (or/UPOG,/CITING.UP)

EPD, SO
EPY, SO
CS, EMLED
EM
Not displayed
FS

GEN
GN
GO
AUGR
ISN, SO

SO
LA
REM.CNTNA
NR, SOOS
PD, SOPY, SOSO

CAS Registry Numbers and Enzyme Codes can also be searched in this field. A /CN Thesaurus is available online. Starting on
November 19, 2000, a new relationship, +XUSE, has been defined for EXPAND and SEARCH in the /CN field. XUSE includes both
USE and UF terms. When you EXPAND in the /CN field, a message is displayed if additional terms are available by using the +XUSE
relationship. If there are additional USE or UF terms available for a search in the /CN field, they are automatically included in the
search.
MeSH Tree Numbers are also searched in this field. (L) proximity is available with Qualifiers. Postings for MeSH Headings do notinclude narrower terms, while MeSH Tree Numbers do include all narrower levels. /CT and /MN Thesauri are available online. Startingon November 19, 2000, a new relationship, +XUSE, has been defined for EXPAND and SEARCH in the /CT field. XUSE includes both
USE and UF terms. When you EXPAND in the /CT field, a message is displayed if additional terms are available by using the +XUSE
April 2017

4
LMEDLINE
relationship. If there are additional USE or UF terms available for a search in the /CT field, they are automatically included in the
search.
(3) This field is not available for records in the OLDMEDLINE file segment.
(4) Search with implied (S) proximity is available in this field.
(5) Both STN standard document types and original NLM publication types (displayed in parenthesis) are searchable separately as boundphrases.
(6) Numeric search field that may be searched using numeric operators or ranges.
(7) The presence of AB, CN, CS, EML, NA, OS, RN, ST fields can be searched in the /FA field; as well as the sections of the structured
abstract: Background, Conclusions, Methods, Objective, and Results.
(8) Enter HELP FS at an arrow prompt for definitions of the FS codes.
(9) Data indexed in this field only until 1996.
(10) Subject of biographical or related article.
(11) Enter HELP OS for information on the content of this field.
(12) The EXPAND command is not available for use in this field.
(13) When author’s name entered with multiple initials, automatically also searches the author’s name with a single initial.

Limiting Search Codes
Only an answer set created in MEDLINE may be limited. L-number answer sets created by as search in the /ED
or /UP field may also be limited.
Search Field Name
Animal Subject (1)English-Language Records
Female Subject (1)Human Subject (1)Major Descriptor (1)Male Subject (1)SearchCode/ANIMAL/ENG/FEMALE/HUMAN/MAJ/MALE

Search Examples
S L4/ANIMAL
S L1/MAJ,ENG (2,3)
S L3/FEMALE
S L1/HUMAN
S L1/MAJ
S L2/MALE(1) Not available in OLDMEDLINE file segment.
(2) Field codes may be abbreviated to the first three letters.
(3) Answer sets may be limited to more than one area.

Chemical Name (/CN) Thesaurus
All Relationship Codes can be used with both the SEARCH and EXPAND command in the Chemical Name(/CN) thesaurus.
The /CN thesaurus does not apply to the OLDMEDLINE file segment.
Code
ALL

AUTO (1)
HM
NOTE
PFT
RN

RR
XUSE

Content
All associated terms(SELF, CN, RN, EC, UF, USE, RR, HM, PA, INDX, NOTE,
PNTE, RE)
Automatic Relationship Code
(SELF, USE)
Heading Mapped to(SELF, CN, RN, EC, RR, HM)
Notes associated with the term
(SELF, CN, RN, EC, RR, INDX, PA, NOTE, PNTE, RE)
Preferred and Forbidden Terms(SELF, CN, RN, EC, RR, UF, USE)
CAS Registry Number associated with the name or nameassociated with a CAS Registry Number(SELF, CN, RN, EC)
Associated CAS Registry Numbers and UNII Codes(SELF, CN, RN, EC, RR)
USE and UF terms from the current MeSH

ExamplesE CHAETOGLOBOSINS+ALL/CN
E 86414-29-1+ALL/CN
E BROMOACETIC ACID+AUTO/CNE CADMIUM ACETATE+HM/CN
E SERICYSTATIN+NOTE/CNE EC 2.4.1.119+NOTE/CNE COMBRETASTATIN+PFT/CNS ARGINYLPROLINE+RN/CN
E 2418-69-1+RN/CN
E FLUVALINATE+RR/CNE BKJ8M8G5HI+RR/CN
E 6-CHRYSENYLAMINE+XUSE/CN
S 6-CHRYSENAMINE+XUSE/CN(1) AUTOMATIC relationship is SET OFF. In case of SET REL ON, the result of EXPAND without any relationship code is the same as
described for AUTO.
April 2017

5
LMEDLINE

Field Descriptors for the /CN Thesaurus
Code
-->
CN
EC
HM
INDX
NOTE
PA
PNTE
RE
RN
RR
UF
USE

Description
Self
Chemical Name and Enzyme Name
Enzyme Commission Numbers
Heading Mapped To
Indexer Note
Scope Note
Pharmacological Action
Previous Indexing Note
Reference
CAS Registry Number
Related Registry Numbers and UNII Codes
Used For
Use

April 2017

6
LMEDLINE

Controlled Term (/CT) Thesaurus
All Relationship Codes can be used with both the SEARCH and EXPAND command in the Controlled Term(/CT) thesaurus.
The /CT thesaurus contains the current Controlled Terms. MeSH Tree Numbers are searchable terms in the/CT thesaurus.
The /CT and /MN Thesauri have the same EXPAND abilities except when expanding MeSH Tree Numbers. The/CT Thesaurus will expand the same Tree Number hierarchy, while the /MN Thesaurus will expand the MeSH
terms corresponding to the various MeSH Tree Numbers.
The /CT thesaurus does not apply to the OLDMEDLINE file segment.
Code
ALL

AUTO (1)

BT
HIE
KT
MN
NOTE

NT
PFT
QLF

QPFT
RT
STD
UF
USE
XUSE

Content
All associated terms(BT, SELF, MN, DC, NOTE, INDX, ENTC, AQ, PNTE,
HNTE, MHTH, BXTH, PA, UF, USE, QUSE, NT, QLF,
QA, QCAT, QNOTE, QINDX, QHNTE, QONTE, QUF,
RT)
Automatic Relationship Code (Preferred Terms andQualifiers)(SELF, USE, QUSE)Broader Terms(BT, SELF, MN)
Hierarchy (Broader and Narrower Terms)(BT, SELF, MN, NT)
Keyword Terms(SELF, KT)
Tree Number and descriptor class(SELF, MN, DC)
Notes associated with the term
(SELF, MN, NOTE, INDX, ENTC, AQ, PNTE, HNTE,
ONTE, MHTH, BXTH, PA)
Narrower Terms(SELF, MN, NT)
Preferred and Forbidden Terms(SELF, MN, ENTC, AQ, UF, USE)
Qualifier and associated terms(SELF, AQ, QUSE, QLF, QA, QCAT, QNOTE, QINDX,QHNTE, QONOTE, QUF)
Qualifier Preferred(SELF, QUSE, QLF, QUF)
Related Terms(SELF, MN, RT)
Standard (Broader, Narrower, and Related Terms)(BT, SELF, MN, NT, RT)
Used For (Forbidden Terms)(SELF, MN, UF)
Use (Preferred Terms)(SELF, MN, USE)
USE and UF terms from the current MeSH

ExamplesE PEPTIC ULCER+ALL/CT
E C6.405.608+ALL/CT

E NASAL SINUSES+AUTO/CT
E ADV EFF+AUTO/CT
E PREGNANCY TESTS+BT/CT
E RECEPTORS, DRUG+HIE/CTS SHOCK+KT/CT
E PROSTHESIS FAILURE+MN/CT
S NUTRITIONAL STATUS+MN/CT
E PEPTIC ULCER+NOTE/CTS NEURONS+NT/CT
E FIBRIN TISSUE ADHESIVE+PFT/CTS ADVERSE EFFECTS+QLF/CT

E PSYCHOLOGY+QPFT/CT
E NEURONS+RT/CT
S SPINAL CORD+STD/CT
E PNEUMONIA+STD/CT
E F1.145.775.+UF/CT
E SEX BEHAVIOR+UF/CT
E GRAAFIAN FOLLICLE+USE/CT
E RADICULITIS+XUSE/CT(1) AUTOMATIC relationship is SET OFF. In case of SET REL ON, the result of EXPAND without any relationship code is the same as
described for AUTO.

April 2017

7
LMEDLINE

Field Descriptors for the /CT Thesaurus
Code
-->
AQ
BT
BXTH
DC
ENTC
HNTE
INDX
KT
MH
MHTH
MN
NOTE
NT
ONTE
PA
PNTE
QA
QCAT
QHNTE
QINDX
QLF
QNOTE
QONTE
QUF
QUSE
RT
UF
USE

Description
Self
Allowable Qualifier
Broader Term
Backwards Cross Reference Thesaurus
Descriptor Class
Entry Combination
History Note
Indexer Note
Keyword Terms
MeSH Heading
MH Thesaurus
MeSH Tree Number
Scope Note, Consider Also Terms
Narrower Term
Online Note
Pharmacological Action
Previous Indexing Note
Qualifier Abbreviation
Allowable Categories
Qualifier History Note
Qualifier Indexer Note
MeSH Qualifier (subheading)
Qualifier Scope Note
Qualifier Online Note
Qualifier Use For
Qualifier Use
Related Term
Used For
Use

April 2017

8
LMEDLINE

MeSH Tree Number (/MN) Thesaurus
In the MeSH Tree Number (/MN) Thesaurus, all Relationship Codes can be used only with the EXPAND
command.
The /MN Thesaurus does not have any postings. When searching, it is necessary to edit the field code to /CT.
The /CT and /MN Thesauri have the same EXPAND abilities except when expanding MeSH Tree Numbers. The/CT Thesaurus will expand the same Tree Number hierarchy, while the /MN Thesaurus will expand the MeSH
terms corresponding to the various MeSH Tree Numbers.
The /MN thesaurus does not apply to the OLDMEDLINE file segment.
Code
ALL

AUTO (1)
BT
HIE
KT
MN
NOTE

NT
PFT
QLF

QPFT
RT
STD
UF
USE
XUSE

Content
All associated terms(BT, SELF, MN, MH, EC, DC, NOTE, INDX, ENTC, AQ,
PNTE, HNTE, ONTE, MHTH, BXTH, PA, UF, USE, QUSE,NT, QLF, QA, QCAT, QNOTE, QINDX, QHNTE, QONTE,
QUF, RT)
Automatic Relationship Code (Preferred Terms and Qualifiers)(SELF, USE, QUSE)Broader Terms(BT, SELF, MN, MH)
Hierarchy (Broader and Narrower Terms)(BT, SELF, MN, MH, NT)
Keyword Terms(SELF, KT)
Tree Number and descriptor class(SELF, MN, MH, DC)
Notes associated with the term
(SELF, MN, MH, NOTE, INDX, ENTC, AQ, PNTE, HNTE,
ONTE, MHTH, BXTH, PA)
Narrower Terms(SELF, MN, MH, NT)
Preferred and Forbidden Terms(SELF, MN, MH, ENTC, AQ, UF, USE)
Qualifier and associated terms(SELF, AQ, QUSE, QLF, QA, QCAT, QNOTE, QINDX,QHNTE, QONTE, QUF)
Qualifier Preferred(SELF, QUSE, QLF, QUF)
Related Terms(SELF, MN, MH, RT)
Standard (Broader, Narrower, and Related Terms)(BT, SELF, MN, MH, NT, RT)
Used For (Forbidden Terms)(SELF, MN, MH, UF)
Use (Preferred Terms)(SELF, MN, MH, USE)
USE and UF terms from the current MeSH

ExamplesE GRANULOMA+ALL/MN
E C23.550.382+ALL/MN

E PANCREATIC CHOLERA+AUTO/MN
E ILLUSIONS+BT/MN
E CHLAMYDIA+HIE/MN
E B3.440.190.190.190.+HIE/MN
E DIET+KT/MN
E ABSCESS+MN/MN
E SPINAL NERVES+NOTE/MN
E A8.800.350.380+NOTE/MN
E TOOTH+NT/MN
E HUMAN ADENOVIRUSES+PFT/MN
E B4.909.777.731.589.520+PFT/MN
E AE+QLF/MN

E METABOLISM+QPFT/MN
E TOMOGRAPHY, EMISSIONCOMPUTED+RT/MN
E ALCOHOLISM+STD/MN
E C21.739.100.250.+STD/MN
E IODIDE PEROXIDASE+UF/MN
E OPHTHALMIA+USE/MN
E ARSENIC POISONING+XUSE/MN(1) AUTOMATIC relationship is SET OFF. In case of SET REL ON, the result of EXPAND without any relationship code is the same as
described for AUTO.

April 2017

9
LMEDLINE

Field Descriptors for the /MN Thesaurus
Code
-->
AQ
BT
BXTH
DC
ENTC
HNTE
INDX
KT
MH
MHTH
MN
NOTE
NT
ONTE
PA
PNTE
QA
QCAT
QHNTE
QINDX
QLF
QNOTE
QONTE
QUF
QUSE
RT
UF
USE

Description
Self
Allowable Qualifier
Broader Term
Backwards Cross Reference Thesaurus
Descriptor Class
Entry Combination
History Note
Indexer Note
Keyword Terms
MeSH Heading
MH Thesaurus
MeSH Tree Number
Scope Note, Consider Also Terms
Narrower Term
Online Note
Pharmacological Action
Previous Indexing Note
Qualifier Abbreviation
Allowable Categories
Qualifier History Note
Qualifier Indexer Note
MeSH Qualifier (subheading)
Qualifier Scope Note
Qualifier Online Note
Qualifier Use For
Qualifier Use
Related Term
Used For
Use

April 2017

10
LMEDLINEDISPLAY and PRINT Formats
Any combination of formats can be used to display or print answers. Multiple codes must be separated by spaces orcommas, e.g., D L1 1-5 TI AU. The fields are displayed in the order requested.
Hit-term highlighting is available in all fields except CM, ED, and PY. Highlighting must be ON to use the HIT, HITIND,
KWIC, and OCC formats.
FormatContent

AB
ABLA
AN (1)
AU
AUCL
AUGR
AUID
AUPB (2,4)
AUTH
CM (1)
CN (1)CS (1)CT (1)CY (1)
DN (1)
DOI (FTDOI)DT (1)ED (1)EM (1)EML (1,2)
EPD (1,2)
EPY (1,2)
FS (1)GEN (1)GNGO
ISN (1,2)
ISSUE (2)
JT (1,2)
JTA (1,2)
JTF (1,2)
LA (1)
NA (1)NCT
NR (1,2)
OS (1)
OS.G (OS.CITING.AN)
OS.GMAX
OSC.G (CITING.CNT)
PD (1,2)
PGNO (2)PY (1,2)
RE
RE.CNT (REC)REM.CNTRN (1)SO
ST (1)
TC (1,2)
TI (1)UNIIUP
UPI
UPOS.G (CITING.UP)
VL (2)

Abstract
Abstract Language (other)
Accession Number
AuthorCollaborators
Group Authors
Author Identifier
Authors in Publication Order
Author Group
Comment
Chemical Name (enzyme code and name)
Corporate Source
Controlled Term (MeSH terms, qualifiers)
Country of Publication
Document Number and PubMed ID
Digital Object Identifier
Document Type
Entry Dates
Entry MonthE-mail Address
Electronic Publication Date
Electronic Publication Year
File Segment
Gene Name
Grant Number
Grant Organization
International Standard (Document) Number
Issue
Journal Title (includes JTA and JTF)
Journal Title, Abbreviated
Journal Title, Full
Language
Named Person (subject of biography or related article)
Clinical Trial Numbers
Number of Report
Other Source
Citing Reference Accession Numbers (up to 50 accession numbers)
Citing Reference Accession Numbers (up to 1020 accession numbers)
Citing Reference Count
Publication Date
Page Number
Publication YearMEDLINE Cited References
Cited References CountMEDLINE Cited References CountCAS Registry Number (Registry Number and chemical name)SourceSupplementary Term
Treatment Code
Title
Unique Ingredient Identifier
Update Date
Update Date Indexing Added
Date Last Citing Reference Entered STN
VolumeApril 2017

ExamplesD 1-5 AN, AB
D ABLA
D 1-5 AND AU TI 2
D AUCLD AUGRD AUID
D AUPBD AUTH
D AN CM TI 1-5
D CN, RN 8-10
D CS, AU 10-20
D AN CT 1-2
D CY TI
D DN
D DOI, D FTDOID DT TI
D ED
D TI SO EM
D EML
D EPD
D EPY
D FS TI 1-2
D GEN TI 1-2
D GN
D GO
D 2 6 ISND ISSUE
D 1-3 JT
D JTA
D JTF
D LA TI
D AN TI NA
D NCT
D NR
D TI SO OS
D OS.GD OS.GMAX
D OSC.GD PY SOD PGNO
D PY
D RE
D RE.CNT
D REM.CNT
D CT RN
D SO TI FS
D ST
D TC
D TI 1-10
D UNIID UP
D UPI, D ED
D UPOS.G
D VL

11
LMEDLINE

Display and Print Formats (cont'd)Format
ABS
ALL

AU.CS
AUTH
BIB
CBIB
DALL
IABS
IALL
IBIB
IND (1)OSG
OSG.MAX
RAN.MEDLINE (n)RETAB (RETABLE)
SCAN (3)
TRIAL (FREE,
SAM) (1)HIT
HITIND (1)KWIC
OCC (1)

Content

ExamplesAB, ABLA
AN, DN, TI, AU.CS, SO, DOI, CM, CY, DT, LA, FS, NCT, OS, EM, ED, AB,
ABLA, ST, CT, RN, CN, UNII, GO, GN, NA, GEN, OSC.G, UPOS.G,
OS.G, RE.CNT, REM.CNT, RE
AU, AUID, CS (AU,AUID, CS repeat as needed), AUGR, AUID, CS(AUGR, AUID, CS repeat as needed), AUCL
AU, AUCL, AUGRAN, DN, TI, AU.CS, SO, DOI, CY, DT, LA, FS, NCT, OS, EM, ED, UP, GO,
GN, OSC.G, UPOS.G, OS.G, RE.CNT, REM.CNT (BIB is the default)
Compressed bibliographic information
ALL, delimited for post-processing
ABS, with a text label
ALL, indented with text labels
BIB, indented with text labels
CT, ST, RN, CN, UNII, NA, GEN
OSC.G, UPOS.G, OS.G (up to 50 accession numbers)
OSC.G, UPOS.G, OS.G (up to 1020 accession numbers)
Cited Reference(s) display feature (n=cited reference number(s)MEDLINE Cited References Table
TI, ST, CT, RN, CN, NA, GEN (random display without answer numbers)
TI, ST, CT, RN, CN, NA, GEN

D ABS 1-3
D 1-3 ALL

Fields containing hit terms
IND
Hit term with 20 words on either side (KeyWord-In-Context)
Fields that contain hit terms and number of times they occur

D HIT 5-10
D HITINDD KWIC 5-10
D OCC L3 1-2

D AU.CSD AUTHD 8 BIB
D 2 CBIBD DALL
D IAB
D IALLD IBIBD BIB, IND
D OSG
D OSG.MAXD RAN.MEDLINE (n)D RETABD SCAN
D TRI(1) No online display fee for this format.
(2) Custom display only.
(3) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.
(4) If 100 or more authors are provided, only the first 99 are presented followed by et al.

Displaying MEDLINE documents for cited references
Enter the following in the DISPLAY command: L-number for the answer set; answer number (only one may be
specified); RAN.MEDLINE(x-y) where (x-y) is the cited reference number, numbers, or range of numbers; andthe display format for the document to display, e.g., BIB ABS. For example, to display MEDLINE records for thecited references 1 and 2 from answer 2 in the answer set L5, enter the following:=> D L5 2 RAN.MEDLINE(1-2) BIB ABS

SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).
Field Name
Abstract
Abstract Language (other)
Accession Number
Accession Number of the Cited Reference in MEDLINE
AuthorAuthor Group

Field Code
AB
ABLA
AN
RAN.MEDAUAUTHANALYZE/
SELECT (1)
Y
Y
Y
Y
Y
Y

SORT
N
N
N
N
Y
N
April 2017

12
LMEDLINE

SELECT, ANALYZE, and SORT Fields (cont'd)
Field Name
Author Identifier
Authors in Publication Order
CAS Registry Number
Chemical Name
Chemical Name and CAS Registry Number
Citation
Cited Reference First Author
Cited Reference Publication Year
Cited Reference Publication Name
Cited References
Cited References Count
Citing Reference Accession Numbers
Citing Reference Count
Clinical Trial Numbers
Collaborators
Comment
Corporate Source
Controlled Term
Country of Publication
Document Number
Document Type
Email Address
Electronic Publication Date
Electronic Publication Year
Entry Month
File Segment
GenBank Number
Gene Name
Grant Number
Grant Organization
Group Author
Hit Cited Reference
International Standard (Document) Number (ISSN)
International Standard Serial Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Journal Title Code
Language
MEDLINE Cited References Count
Named Person
Number of Report
Occurrence Count of Hit Terms
Other Source
Publication Date
Publication Year
SourceSupplementary Term
Title
Treatment Code
Unique Ingredient Identifier
Date Last Citing Reference Entered STN

Field Code
AUID
AUPB
RN
CN
NAME
CHEM
CIT
RAU
RPY
RWK
RE
RE.CNT
OS.G (OS.CITING.AN)
OSC.G (CITING.CNT)
NCT
AUCL
CM
CS
CT
CY
DN
DT
EML
EPD
EPY
EM
FS
GENBANK (GBN)
GEN
GN
GO
AUGR
HITRE
ISN
ISSN
JT
JTA
JTF
JTC
LA
REM.CNT
NA
NR
OCC
OS
PD
PY
SO
ST
TI
TC
UNII
UPOS.G (UPOG,
CITING.UP)

ANALYZE/
SELECT (1)SORTYY (12)
Y (2,3,4)
Y (4)Y (2,4)
Y (2,4)Y (4,5)
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y (10)
Y
Y
Y
Y (6)
Y
Y
Y
Y
Y
Y
Y (2,11)
Y
Y
Y
Y
N
Y (7)
N
Y
Y (8)
Y (8)
Y
Y
Y
Y
Y
N
Y
Y
Y (4)
Y (9)
Y (2)
Y (default)
Y
Y
Y

Y
N
N
N
N
N
N
N
N
N
N
Y
Y
Y
Y
N
N
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
N
N
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
N
N
Y
Y
N
Y

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HIT TI.
(2) Appends /BI to the terms created by SELECT.
(3) Only extracts CAS Registry Numbers.
(4) SELECT HIT and ANALYZE HIT are not valid with this field.
(5) Extracts first author, publication year, volume, and first page with a truncation symbol appended and with /RE appended to the terms
created by SELECT. This field can be used for cross-file searching in SCISEARCH and CAplusSM.
(6) Selects or analyzes MEDLINE's Document Number and the PubMed ID.
April 2017

13
LMEDLINE(7) Selects or analyzes the ISSN and CODEN.
(8) Appends /JT to the terms created by SELECT.
(9) Selects or analyzes the ISSN, CODEN, and journal code with /SO appended to the terms created by SELECT.
(10) Selects or analyzes the PMID values with /DN appended.
(11) SELECT GENBANK selects GenBank numbers from the OS field.
(12) Appends /AU to the terms created by SELECT.

Sample Records
DISPLAY IALLACCESSION NUMBER:
DOCUMENT NUMBER:
TITLE:AUTHOR:
CORPORATE SOURCE:

AUTHOR:GROUP AUTHORS:COLLABORATORS:SOURCE:DIGITAL OBJECT ID:
PUB. COUNTRY:DOCUMENT TYPE:LANGUAGE:
FILE SEGMENT:
FILE SEGMENT:ENTRY MONTH:ENTRY DATE:

2010222995
LMEDLINE Full-text
PubMed ID: 20202800
Drug attitude as predictor for effectiveness infirst-episode schizophrenia: Results of an open randomized
trial (EUFEST).
Gaebel Wolfgang
Department of Psychiatry and Psychotherapy,
Heinrich-Heine-University Dusseldorf, Rhineland StateClinics Dusseldorf, Germany.
wolfgang.gaebel@uni-duesseldorf.de
Riesbeck Mathias; von Wilmsdorff Martina; Burns Tom; Derks
Eske M; Kahn Rene S; Rossler Wulf; Fleischhacker W Wolfgang
Group Authors: EUFEST Study Group
Collaborators: Kahn R S; Fleischhacker W W; Boter H; KeetI P M; Brugman C; Davidson M; Dollfus S; Gaebel W;
Galderisi J; Gheorghe M; Gonen I; Grobbee D E; Hranov L G;
Hummer M; Libiger J; Lindefors N; Lopez-Ibor J J; Nijssen
K; Peuskens J; Prelipceanu D; Riecher-Rossler A; Rybakowski
J K; Sedvall G; Wilmsdorff M v
European neuropsychopharmacology : the journal of theEuropean College of Neuropsychopharmacology, (2010 May)
Vol. 20, No. 5, pp. 310-6. Electronic Publication Date: 3
Mar 2010
Journal code: 9111390. E-ISSN: 1873-7862. L-ISSN:
0924-977X.
http://dx.doi.org/10.1016/j.euroneuro.2010.02.001
Netherlands
Journal; Article; (JOURNAL ARTICLE)(RANDOMIZED CONTROLLED TRIAL)(RESEARCH SUPPORT, NON-U.S. GOV'T)(CLINICAL TRIAL)
EnglishMEDLINE; Priority Journals
Print; Electronic
201006Entered STN: 1 Apr 2010
Last Updated on STN: 15 Jun 2010
Entered Medline: 14 Jun 2010

ABSTRACT:
Effectiveness has become more and more important as a comprehensive outcome
measure for (long-term) treatment in schizophrenia. Early predictors to
identify patients at a high risk for not succeeding the initiated treatment
would be very useful. Discontinuation of the initiated treatment was used as● ● ●These findings have to be validated in other (first-episode) samples.
2010 Elsevier B.V. and ECNP. All rights reserved.
CONTROLLED TERM:
Check Tags: Female; Male
Adult
*Antipsychotic Agents: TU, therapeutic use
Benzodiazepines: TU, therapeutic use
Dibenzothiazepines: TU, therapeutic use
Haloperidol: TU, therapeutic use
Humans*Medication Adherence: PX, psychology
Piperazines: TU, therapeutic use
Psychiatric Status Rating Scales
April 2017

14
LMEDLINE
Questionnaires
ROC Curve*Schizophrenia: DT, drug therapy*Schizophrenic Psychology
Sulpiride: AA, analogs & derivatives
Sulpiride: TU, therapeutic use
Thiazoles: TU, therapeutic use
Treatment Outcome
CAS REGISTRY NO.:
12794-10-4 (Benzodiazepines); 132539-06-1 (olanzapine);
146939-27-7 (ziprasidone); 15676-16-1 (Sulpiride);
53583-79-2 (sultopride); 52-86-8 (Haloperidol)
CHEMICAL NAME:
Antipsychotic Agents; Dibenzothiazepines; Piperazines;
Thiazoles; quetiapine
UNIQ INGREDIENT ID: 6UKA5VEJ6X; 7MNE9M8287; AA0G3TW31W; BGL0JSY5SI; J6292F8L3D
OS.CITING REF COUNT: 3
There are 3 MEDLINE records that cite this record
DATE LAST CITED:
Date last citing reference entered STN: 23 Feb 2013
OS.CITING.REFS:MEDLINE 2013403009; 2012930008; 2011244493

DISPLAY IALL (OLDMEDLINE File Segment)
ACCESSION NUMBER:
1960000021
LMEDLINE
DOCUMENT NUMBER:
PubMed ID: 13680875
TITLE:The effect of atropine, propantheline and poldine on thevagally stimulated gastric motility and thehistamine-stimulated acid gastric secretion in the rat.
AUTHOR:AARSEN P N; van NOORDWIJK J
SOURCE:
British journal of pharmacology and chemotherapy, (1961
Aug) Vol. 17, pp. 41-50.
Journal code: 0154627. ISSN: 0366-0826. L-ISSN: 0366-0826.
DOCUMENT TYPE:
Journal; Article; (JOURNAL ARTICLE)LANGUAGE:
EnglishFILE SEGMENT:OLDMEDLINE; NONMEDLINEOTHER SOURCE:
NLMPMC1482058
ENTRY MONTH:
199811ENTRY DATE:Entered STN: 16 Jul 1999
Last Updated on STN: 16 Jul 1999
Entered Medline: 1 Nov 1998
ABSTRACT:
Histamine-induced acid gastric secretion in the anaesthetized rat was notdiminished by poldine in a dose which reduced vagally stimulated gastriccontractions by approximately 75%. A dose of atropine, twice as large as thedose which reduced gastric contractions by 75%, had no apparent effect on thehistamine-stimulated acid gastric secretion up to 2 hr after the injection.
Only when more than 40 times as much atropine was injected did a slightinhibition of the acid secretion occur in 80 to 120 min. Propantheline, in adose which inhibited gastric contractions by approximately 75%, slightly
diminished acid secretion in 40 to 80 min. This effect was not increased by afurther dose of propantheline. It was concluded that, in so far as any
inhibition of acid gastric secretion had occurred, this could not beinterpreted as an anti-muscarine or a direct toxic effect, but rather as anindirect effect possibly due to interference with the blood flow through thestomach wall.
SUPPLEMENTARY TERM: atropine - pharmacology; gastric juice; histamine pharmacology; methantheline - related compounds;
parasympatholytics - pharmacology; stomach
CONTROLLED TERM:*Atropine: PD, pharmacology*Gastric Juice*Histamine: PD, pharmacology*Parasympatholytics: PD, pharmacology
Quaternary Ammonium Compounds*Stomach
CAS REGISTRY NO.:5818-17-7 (methantheline); 51-45-6 (Histamine); 51-55-8(Atropine)
CHEMICAL NAME:
Parasympatholytics; Quaternary Ammonium Compounds
UNIQ INGREDIENT ID: 36EI79TX7I
OS.CITING REF COUNT: 1
There are 1 MEDLINE records that cite this record
April 2017

15
LMEDLINE
MEDLINE REFERENCE COUNT:8

There are 8 cited references available in
MEDLINE for this document.
REFERENCE(S):CITED REFERENCES AVAILABLE IN MEDLINE(1) ACRED, P; Br J Pharmacol Chemother. 1957 Dec, V12(4), P447-52. MEDLINE(2) CODE, C F; Pharmacol Rev. 1951 Mar, V3(1), P59-106. MEDLINE(3) GHOSH, M N; Br J Pharmacol Chemother. 1958 Mar, V13(1), P54-61. MEDLINE(4) HOLLANDER, F; Am J Physiol. 1956 Sep, V186(3), P373-6. MEDLINE(5) NORDGREN, B; Acta Physiol Scand. 1957 Oct 22, V40(4), P297-304. MEDLINE(6) Polland, W S; J Clin Invest. 1930 Oct, V9(2), P319-32. MEDLINE(7) THOMPSON, J E; J Physiol. 1953 Sep, V121(3), P433-44. MEDLINE(8) VAN NOORDWIJK, J; Br J Pharmacol Chemother. 1954 Sep, V9(3), P253-9.
MEDLINEDISPLAY BIB
AN
2014023012
LMEDLINE
DN
PubMed ID: 24076990
TI
Cas9 as a versatile tool for engineering biology.
AU
Mali PrashantCS
Department of Genetics, Harvard Medical School, Boston, Massachusetts,
USA.
AU
Esvelt Kevin M; Church George M
AUID ORCID: http://orcid.org/0000-0001-8797-3945
SO
Nature methods, (2013 Oct) Vol. 10, No. 10, pp. 957-63.
Journal code: 101215604. E-ISSN: 1548-7105. L-ISSN: 1548-7091.
Report No.: NLM-NIHMS585731; NLM-PMC4051438.
DOI http://dx.doi.org/10.1038/nmeth.2649
CY
United States
DT
Journal; Article; (JOURNAL ARTICLE)(RESEARCH SUPPORT, N.I.H., EXTRAMURAL)(RESEARCH SUPPORT, NON-U.S. GOV'T)(RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.)
General Review; (REVIEW)LA
EnglishFSMEDLINE; Priority Journals
FS
Print
EM
201312EDEntered STN: 1 Oct 2013
Last Updated on STN: 20 Dec 2013
Entered Medline: 11 Dec 2013GO
United States NHGRI NIH HHS
GN
P50 HG005550
OSC.G 30
There are 30 MEDLINE records that cite this record
REM.CNT 75
There are 75 cited references available in MEDLINE for thisdocument.
DISPLAY TRIAL
TI
Combination therapy using aspirin-enhanced photodynamic selective drugdelivery.
CT
Animals*Aspirin: PD, pharmacology*Blood Vessels: DE, drug effects
Chick Embryo
Combined Modality Therapy
Cyclooxygenase Inhibitors: PD, pharmacology*Drug Delivery Systems
Fluorescein Angiography
Heparin: PD, pharmacology
Macular Degeneration: DT, drug therapy
Macular Degeneration: TH, therapy
Neoplasms: DT, drug therapy
Neoplasms: TH, therapy*Photochemotherapy: MT, methods
Photosensitizing Agents: PD, pharmacology
Porphyrins: PD, pharmacology
RN
129497-78-5 (verteporfin); 50-78-2 (Aspirin); 9005-49-6 (Heparin)
CN
Cyclooxygenase Inhibitors; Photosensitizing Agents; Porphyrins
April 2017

16
LMEDLINE
EXPAND in /CN Thesaurus=> E NIFENALOL+ALL/CN
E10--> nifenalol/CN
E2
0
RN
5054-57-9/CN
E3
0RR
5302-35-2/CN((R)-isomer)
E40
RR
5302-36-3/CN((S)-isomer)
E50
RR
5704-60-9/CN(mono-HCl(+-)-isomer)
E60
RR
7349-37-3/CN(mono-HCl(S)-isomer)
E70
RR
7388-03-6/CN(mono-HCl(R)-isomer)
E80
RR
7413-36-7/CN((+-)-isomer)
E90UF
1-(4-nitrophenyl)-2-isopropylaminoethanol/CN
E100UF
inpea/CN
E11
0UF
nifenalol monohydrochloride, (+-)-isomer/CN
E120UF
nifenalol monohydrochloride, (R)-isomer/CN
E130UF
nifenalol monohydrochloride, (S)-isomer/CN
E140UF
nifenalol, (+-)-isomer/CN
E150UF
nifenalol, (R)-isomer/CN
E160UF
nifenalol, (S)-isomer/CN
HM*Ethanolamines
NOTE adrenergic beta-blocker with good antiarrhythmic
properties; also tends to lower blood pressure &provide protection against angina; minor
descriptor(75-86); on-line & INDEX MEDICUS search
ETHANOLAMINES (75-86); RN given refers to parent cpd
without isomeric designation
PNTE minor descriptor (75-86); file maintained to
ETHANOLAMINES********** END **********EXPAND in /CT Thesaurus=> E PLATELET AGGREGATION INHIBITORS+ALL/CT
E1
0
BT5
D Chemicals and Drugs/CT
E2
0
BT4
Chemical Actions and Uses/CT
E3
0BT3Pharmacologic Actions/CT
E4
0
BT2
Therapeutic Uses/CT
E5
0
BT1
Hematologic Agents/CT
E6
31
-->
Platelet Aggregation Inhibitors/CT
E7
31
MN
D27.505.954.502.780./CT
DC
an INDEX MEDICUS major descriptor
NOTE Drugs or agents which antagonize or impair any
mechanism leading to blood platelet aggregation,
whether during the phases of activation and shapechange or following the dense-granule release
reaction and stimulation of theprostaglandin-thromboxane system.
INDX DF: PLATELET INHIBAQAD AE AG AN BL CF CH CL CS CT DU EC HI IM IP ME
PD PK PO RE SD ST TO TU URPNTE Blood Platelets (1966-1987)
PNTE Platelet Adhesiveness (1972-1987)
PNTE Platelet Aggregation (1976-1987)
HNTE 88
MHTH NLM (1988)
E8
0UF
Agents, Antiplatelet/CT
E90UF
Aggregation Inhibitors, Platelet/CT
E100UF
Antagonists, Blood Platelet/CT
E110UF
Antagonists, Platelet/CT
E120UF
Antiaggregants, Blood Platelet/CT
E13
0UF
Antiaggregants, Platelet/CT
April 2017

17
LMEDLINE
E14
0
UF
E15
0
UF
E16
0
UF
E17
0
UF
E18
0
UF
E19
0
UF
E20
0
UF
E21
0
UF
E22
0
UF
E23
0
UF
E24
0
UF
E25
0
UF
E26
4
NT1
E27
26
NT1
E28
11
NT1
E29
0
NT1
E30
7
NT1
E31
0
NT1
E32
3
NT1
E33
2
NT1
E34
4
NT1
E35
2
NT1
E36
0
NT1
E37
0
NT2
E38
2
NT2
E39
4
NT1
E40
1
NT1
********** END **********

Antiplatelet Agents/CT
Antiplatelet Drugs/CT
Blood Platelet Aggregation Inhibitors/CT
Blood Platelet Antagonists/CT
Blood Platelet Antiaggregants/CT
Drugs, Antiplatelet/CT
Inhibitors, Platelet/CT
Inhibitors, Platelet Aggregation/CT
PLATELET AGGREGATION INHIB/CT
Platelet Antagonists/CT
Platelet Antiaggregants/CT
Platelet Inhibitors/CT
Alprostadil/CT
Aspirin/CT
Dipyridamole/CT
Disintegrins/CT
Epoprostenol/CT
Iloprost/CT
Ketanserin/CT
Milrinone/CT
Pentoxifylline/CT
S-Nitrosoglutathione/CT
S-Nitrosothiols/CT
S-Nitroso-N-Acetylpenicillamine/CT
S-Nitrosoglutathione/CT
Ticlopidine/CT
Trapidil/CT

EXPAND in /MN Thesaurus=> E D13.695.900.380.+ALL/MN
E1
BT7
D Chemicals and Drugs/MN
E2
BT6
Carbohydrates/MN
E3
BT5
Glycosides/MN
E4
BT6
D Chemicals and Drugs/MN
E5
BT5
Nucleic Acids, Nucleotides, and Nucleosides/MN
E6
BT4
Nucleotides/MN
E7
BT7
D Chemicals and Drugs/MN
E8
BT6
Heterocyclic Compounds/MN
E9
BT5
Heterocyclic Compounds, 2-Ring/MN
E10
BT4
Purines/MN
E11
BT3
Purine Nucleotides/MN
E12
BT7
D Chemicals and Drugs/MN
E13
BT6
Carbohydrates/MN
E14
BT5
Glycosides/MN
E15
BT6
D Chemicals and Drugs/MN
E16
BT5
Nucleic Acids, Nucleotides, and Nucleosides/MN
E17
BT4
Nucleotides/MN
E18
BT3
Ribonucleotides/MN
E19
BT2
Guanine Nucleotides/MN
E20
BT1
Guanosine Triphosphate/MN
E21
BT5
D Chemicals and Drugs/MN
E22
BT4
Carbohydrates/MN
E23
BT3
Glycosides/MN
E24
BT4
D Chemicals and Drugs/MN
E25
BT3
Nucleic Acids, Nucleotides, and Nucleosides/MN
E26
BT2
Nucleotides/MN
E27
BT4
D Chemicals and Drugs/MN
E28
BT3
Inorganic Chemicals/MN
E29
BT4
D Chemicals and Drugs/MN
E30
BT3
Organic Chemicals/MN
E31
BT2
Sulfur Compounds/MN
E32
BT1
Thionucleotides/MN
E33-->
D13.695.900.380./MN
E34
MH
Guanosine 5'-O-(3-Thiotriphosphate)/MN
April 2017

18
LMEDLINE
RN
DC
NOTE

INDX
AQ
PNTE
PNTE
HNTE
MHTH
UF
UF
UF
UF
UF
UF

E35
E36
E37
E38
E39
E40

E41
UF
E42
UF
E43
UF
********** END **********

37589-80-3
an INDEX MEDICUS major descriptor
Guanosine 5'-(trihydrogen diphosphate),monoanhydride with phosphorothioicacid. A
stable GTP analog which enjoys a variety ofphysiological actions such as stimulation of
guanine nucleotide-binding proteins,
phosphoinositide hydrolysis, cyclic AMP
accumulation, and activation of specificproto-oncogenes.
/biosyn /physiol permitted
AA AD AE AG AI AN BI BL CF CH CL CS CT DF DU EC
GE HI IM IP ME PD PH PK PORE SD SE ST TO TU UR
Guanosine Triphosphate (1972-1990)
Thionucleotides (1977-1990)
91
NLM (1991)
GTP gamma S/MN
GTPgammaS/MN
GUANOSINE 5 O 3 THIOTRIPHOSPHATE/MN
Guanosine 5'-(3-O-Thio)Triphosphate/MN
Guanosine 5'-(gamma-S)Triphosphate/MN
Guanosine 5'-(trihydrogen diphosphate),
P'-anhydride with phosphorothioic acid/MN
gamma S, GTP/MN
gamma Thio GTP/MN
gamma-Thio-GTP/MNDISPLAY BIB FOR EPUB AHEAD OF PRINT (NOTE: To manage the content of EPUB AHEAD OF PRINT records inyour answer set use EPUB AHEAD OF PRINT/FS)
AN
DN
TI
AU
CS
SO

DT
LA
FS
ED

2021000101
LMEDLINE (EPUB AHEAD OF PRINT)
PubMed ID: 22033324
Online information as a decision making aid for cancer patients:
Recommendations from the Eurocancercoms project.
Maddock Carol; Camporesi Silvia; Lewis Ian; Ahmad Kafait; Sullivan Richard
Tenovus Cancer Charity, Gleider House, Ty Glas Road, Cardiff CF14 5BD,
United Kingdom.
European journal of cancer (Oxford, England : 1990), (2011 Oct 25) .
Electronic Publication: 2011-10-25.
Journal code: 9005373. E-ISSN: 1879-0852. L-ISSN: 0959-8049.
Journal; Article; (JOURNAL ARTICLE)
EnglishEPUB AHEAD OF PRINT; NONMEDLINE; NONINDEXEDEntered STN: 19 Mar 2012
Last Updated on STN: 19 Mar 2012

In North America
CAS
STN North America
P.O. Box 3012
Columbus, Ohio 43210-0012 U.S.A.
CAS Customer Center:Phone: 800-753-4227 (North America)
614-447-3700 (worldwide)Fax:
614-447-3751
Email:
help@cas.org
Internet: www.cas.org

April 2017

In Europe
FIZ Karlsruhe
STN Europe
P.O. Box 2465
76012 Karlsruhe
Germany
Phone: +49-7247-808-555
Fax:+49-7247-808-259
Email:
helpdesk@fiz-karlsruhe.de
Internet: www.stn-international.com

In Japan
JAICI (Japan Association forInternational Chemical Information)
STN Japan
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021, Japan
Phone: +81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)
Fax:+81-3-5978-3600
Email:
support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp